Osborne Clarke advised AlbionVC on the deal. Echopoint Medical, a cardiovascular diagnostic technology company and a UCL spinout, has secured £4.2 million in Series A funding...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised AlbionVC on investment in OpenDialog AI. OpenDialog AI completed a US$13 million Series A fundraising round. AlbionVC led the investment board, other investors...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised FA Bio on the deal. FA Bio, the British bio-tech company with a vision to protect natural ecosystems by identifying superior microbial bio-products...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised StudentCrowd on Series A fundraising. StudentCrowd, a decision-making platform for higher education, completed its Series A fundraising round led by Mercia Ventures. With...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised UCL Technology Fund on the investment. Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised King’s College London on the deal. King’s College London established with ValiRx PLC (“ValiRx”) of Cytolytix Limited (“Cytolytix), a new ValiRx subsidiary formed...
You must be a Standard 1 Year member to access this content.
